Scientists have identified why some patients developed dangerous blood clots called vaccine-induced immune thrombocytopenia and thrombosis (VITT) after…
Locus Biosciences will conduct a clinical trial for its Ai-designed bacteriophage therapeutic for HAP/VAP caused by antibiotic-resistant P. aeruginosa.…